Merck and Eisai report blended leads to Section 3 most cancers trial By Investing.com
RAHWAY, N.J. & NUTLEY, N.J. - Merck (NSE:) & Co., Inc. (NYSE:)…
Merck advances with FDA breakthrough tag for most cancers drug By Investing.com
Merck & Co (NYSE:). Inc. has introduced that the U.S. Meals and…
